Encompass Health (EHC) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
24 Dec, 2025Opening remarks and agenda
Meeting opened with introductions and confirmation of agenda and rules of conduct.
Chair called the meeting to order and declared polls open for voting.
Attendance of board members, executive management, and independent auditors was confirmed.
Corporate governance
Notice of meeting and proxy materials were mailed to stockholders of record.
Inspector of Election was appointed and sworn in; quorum was confirmed.
No director nominations were received from stockholders.
Overview of voting outcomes
Four items were voted on: election of 10 directors, ratification of auditors, executive compensation, and the 2025 Omnibus Performance Incentive Plan.
All 10 director nominees were overwhelmingly elected.
Ratification of PricewaterhouseCoopers LLP as auditors was approved.
Executive compensation and the 2025 Omnibus Performance Incentive Plan were both approved.
Latest events from Encompass Health
- Expansion, innovation, and disciplined capital use drive positive outlook and operational momentum.EHC
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Double-digit growth in revenue, EBITDA, and EPS in 2025, with strong 2026 outlook.EHC
Q4 20256 Feb 2026 - Double-digit revenue and earnings growth in Q1 led to higher full-year guidance.EHC
Q1 20253 Feb 2026 - Q2 2024 revenue rose 9.6% and net income 24.8%, prompting higher full-year guidance.EHC
Q2 20242 Feb 2026 - Q3 2024 saw 11.9% revenue growth, higher earnings, and a raised full-year outlook.EHC
Q3 202418 Jan 2026 - Q4 2024 saw strong growth in revenue, earnings, and cash flow, with a positive 2025 outlook.EHC
Q4 20248 Jan 2026 - Sustained growth, clinical excellence, and capital discipline drive expansion and strong returns.EHC
Barclays 27th Annual Global Healthcare Conference20 Dec 2025 - 2025 meeting features key votes on directors, pay, auditor, and a new performance incentive plan.EHC
Proxy Filing1 Dec 2025 - Q2 2025 delivered double-digit revenue and profit growth, with raised guidance and expansion.EHC
Q2 202523 Nov 2025